WHO’s bold move to make clinical trials fairer for all
In May 2025, the World Health Organization (WHO) published its landmark initiative to address the lack of equity in clinical …
In May 2025, the World Health Organization (WHO) published its landmark initiative to address the lack of equity in clinical …
Findings from a Phase I trial initiated by Dana-Farber Cancer Institute have demonstrated that the NeoVax personalised cancer vaccine’s updated …
According to the World Health Organization, autism spectrum disorder (ASD) affects approximately 10% of children globally. ASD is theorised to …
Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC), but only …
PDS Biotechnology has completed subject recruitment for stage one of its open-label Phase II trial, evaluating the systemic administration of …
With pressures only intensifying on clinical trials, there are major concerns that current models are inefficient and unsustainable. Insight from …
XyloCor Therapeutics has dosed the first subject in the multi-centre, randomised Phase IIb EXACT-2 trial, to assess the gene therapy …
The evolving mRNA landscape has been marked by rapid advancements and a broadening scope of applications, primarily driven by the …
Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries, …
The US Food and Drug Administration's approval of suzetrigine at the start of 2025 was a breakthrough moment for pain …
US-based MAIA Biotechnology has dosed the first subject in Taiwan in the expansion phase of its multicentre THIO-101 Phase II …
According to GlobalData analysis, currently marketed and pipeline cell therapy assets in oncology will generate sales of around $25bn by …
Rhythm Pharmaceuticals is advancing its oral obesity drug bivamelagon to Phase III studies after it significantly reduced body mass index …
Contract development and manufacturing organisations (CDMOs) worldwide are facing a multitude of challenges, which are heightened considerably in oncology by …
Handing over your molecule is a big step for emerging biotechs. The process of developing new drugs is complex and …